Metraipolis › archive › dc_760462f2bd4e

Adapting CAR-T and CAR-Treg cancer therapies for autoimmunity: innovations and challenges — Europe PMC PMID:42148104

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/42148104
DOI: 10.3389/fimmu.2026.1737202
License (as archived): solo-consultazione
Archived: 2026-11-03T00:45:50.854Z
SHA-256 of the archived text: 9ed2c49a10e0d4959aeaf872bc357636ffa17eb04983649396652b6b584494ca
Stable URL of this page: https://metraipolis.com/documento/dc_760462f2bd4e

How to cite

Adapting CAR-T and CAR-Treg cancer therapies for autoimmunity: innovations and challenges — Europe PMC PMID:42148104 — Europe PMC (en), https://europepmc.org/article/MED/42148104 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_760462f2bd4e (Metraipolis archive dc_760462f2bd4e, sha256 9ed2c49a10e0d4959aeaf872bc357636ffa17eb04983649396652b6b584494ca)

BibTeX

@misc{dc760462f2bd4e,
  title = {Adapting CAR-T and CAR-Treg cancer therapies for autoimmunity: innovations and challenges — Europe PMC PMID:42148104},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42148104},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_760462f2bd4e; sha256 9ed2c49a10e0d4959aeaf872bc357636ffa17eb04983649396652b6b584494ca},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42148104. Agents can read the archived copy with the MCP tool read_document.